# The Dose-response "Pilot" Study of Topically Delivered Clobetasol Propionate Lotion in Healthy Adult Subjects

> **NCT00864240** · PHASE1 · COMPLETED · sponsor: **Actavis Inc.** · enrollment: 15 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Clobex TM (Clobetasol) 0.05% Lotion, single exposure

## Key facts

- **NCT ID:** NCT00864240
- **Lead sponsor:** Actavis Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-10
- **Primary completion:** 2005-10
- **Final completion:** 2005-10
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2019-07-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00864240

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00864240, "The Dose-response "Pilot" Study of Topically Delivered Clobetasol Propionate Lotion in Healthy Adult Subjects". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00864240. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*